{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T09:04:57Z","timestamp":1779959097830,"version":"3.53.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172727"],"award-info":[{"award-number":["82172727"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7202164"],"award-info":[{"award-number":["7202164"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Hope Research Institute of Thyroid","award":["2017070101"],"award-info":[{"award-number":["2017070101"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12149-026-02163-7","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T13:39:20Z","timestamp":1771421960000},"page":"624-633","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcome of MRI-Guided Single-Dose Iodine-131 for Graves\u2019 Hyperthyroidism with Large Goiter"],"prefix":"10.1007","volume":"40","author":[{"given":"Shangcheng","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiansheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"2163_CR1","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1001\/jama.2023.19052","volume":"330","author":"SY Lee","year":"2023","unstructured":"Lee SY, Pearce EN. Hyperthyroidism: a review. JAMA. 2023;330:1472\u201383.","journal-title":"JAMA"},{"key":"2163_CR2","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","volume":"26","author":"DS Ross","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26:1343\u2013421.","journal-title":"Thyroid"},{"key":"2163_CR3","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1089\/thy.2023.0332","volume":"33","author":"S Yan","year":"2023","unstructured":"Yan S, Li X, Yan B. Letter to the editor: could radioactive iodine be a preferred therapy for graves\u2019 hyperthyroidism patients with large goiters? A viewpoint from China. Thyroid. 2023;33:1380\u20131.","journal-title":"Thyroid"},{"key":"2163_CR4","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1089\/thy.2023.0423","volume":"33","author":"DS Ross","year":"2023","unstructured":"Ross DS. Response to Yan et al. re: \u201cCould radioactive iodine be a preferred therapy for Graves\u2019 hyperthyroidism patients with large goiters? A viewpoint from China.\u201d Thyroid. 2023;33:1382\u20133.","journal-title":"Thyroid"},{"key":"2163_CR5","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3803\/EnM.2025.2464","volume":"40","author":"KJ Kim","year":"2025","unstructured":"Kim KJ, Song E, Kim M, Kwon H, Ku EJ, Kwon HW, et al. 2025 Korean thyroid association management guidelines for radioactive iodine therapy in patients with hyperthyroidism. Endocrinol Metab (Seoul). 2025;40:342\u201356.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"2163_CR6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.amjsurg.2021.03.068","volume":"223","author":"M Shalaby","year":"2022","unstructured":"Shalaby M, Hadedeya D, Toraih EA, Razavi MA, Lee GS, Hussein MH, et al. Predictive factors of radioiodine therapy failure in Graves\u2019 Disease: a meta-analysis. Am J Surg. 2022;223:287\u201396.","journal-title":"Am J Surg"},{"key":"2163_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.47102\/annals-acadmedsg.V48N6p181","volume":"48","author":"WL Tay","year":"2019","unstructured":"Tay WL, Chng CL, Tien CS, Loke KS, Lam WW, Fook-Chong SM, et al. High Thyroid Stimulating Receptor Antibody Titre and Large Goitre Size at First-Time Radioactive Iodine Treatment are Associated with Treatment Failure in Graves\u2019 Disease. Ann Acad Med Singapore. 2019;48:181\u20137.","journal-title":"Ann Acad Med Singapore"},{"key":"2163_CR8","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1507\/endocrj.EJ20-0836","volume":"68","author":"T Mizokami","year":"2021","unstructured":"Mizokami T, Hamada K, Maruta T, Higashi K, Tajiri J. Utility of outpatient fractionated radioiodine therapy for graves disease involving a large goiter measuring more than 100 mL in volume. Endocr J. 2021;68:1117\u201325.","journal-title":"Endocr J"},{"key":"2163_CR9","first-page":"2802","volume":"63","author":"K Nakada","year":"2022","unstructured":"Nakada K, Mizukoshi T, Tamura M, Kato K, Kato N, SakuraiMD M. Radioiodine therapy for Graves\u2019 hyperthyroidism with a large goiter. J Nucl Med. 2022;63:2802.","journal-title":"J Nucl Med"},{"key":"2163_CR10","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/00006231-200605000-00005","volume":"27","author":"AC Traino","year":"2006","unstructured":"Traino AC, Di Martino F, Grosso M, Monzani F, Dardano A, Caraccio N, et al. A study of the possibility of curing Graves\u2019 disease based on the desired reduction of thyroid mass (volume) as a consequence of 131I therapy: a speculative paper. Nucl Med Commun. 2006;27:439\u201346.","journal-title":"Nucl Med Commun"},{"key":"2163_CR11","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1089\/thy.2021.0302","volume":"31","author":"J Taprogge","year":"2021","unstructured":"Taprogge J, Gape PMD, Carnegie-Peake L, Murray I, Gear JI, Leek F, et al. A systematic review and meta-analysis of the relationship between the radiation absorbed dose to the thyroid and response in patients treated with radioiodine for Graves\u2019 disease. Thyroid. 2021;31:1829\u201338.","journal-title":"Thyroid"},{"key":"2163_CR12","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1210\/jc.2002-020805","volume":"88","author":"WD Leslie","year":"2003","unstructured":"Leslie WD, Ward L, Salamon EA, Ludwig S, Rowe RC, Cowden EA. A randomized comparison of radioiodine doses in graves\u2019 hyperthyroidism. J Clin Endocrinol Metab. 2003;88:978\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"2163_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/958276","volume":"2013","author":"JM Dora","year":"2013","unstructured":"Dora JM, Escouto Machado W, Andrade VA, Scheffel RS, Maia AL. Increasing the radioiodine dose does not improve cure rates in severe graves\u2019 hyperthyroidism: a clinical trial with historical control. J Thyroid Res. 2013;2013:958276.","journal-title":"J Thyroid Res"},{"key":"2163_CR14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.2967\/jnumed.120.243170","volume":"62","author":"G Mariani","year":"2021","unstructured":"Mariani G, Tonacchera M, Grosso M, Orsolini F, Vitti P, Strauss HW. The role of nuclear medicine in the clinical management of benign thyroid disorders, part 1: hyperthyroidism. J Nucl Med. 2021;62:304\u201312.","journal-title":"J Nucl Med"},{"key":"2163_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1259\/0007-1285-67-798-519","volume":"67","author":"DA Huysmans","year":"1994","unstructured":"Huysmans DA, de Haas MM, van den Broek WJ, Hermus AR, Barentsz JO, Corstens FH, et al. Magnetic resonance imaging for volume estimation of large multinodular goitres: a comparison with scintigraphy. Br J Radiol. 1994;67:519\u201323.","journal-title":"Br J Radiol"},{"key":"2163_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2214\/ajr.179.1.1790259","volume":"179","author":"SJ Bonnema","year":"2002","unstructured":"Bonnema SJ, Andersen PB, Knudsen DU, Heged\u00fcs L. MR imaging of large multinodular goiters: observer agreement on volume versus observer disagreement on dimensions of the involved trachea. AJR Am J Roentgenol. 2002;179:259\u201366.","journal-title":"AJR Am J Roentgenol"},{"key":"2163_CR17","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1007\/s00259-010-1536-8","volume":"37","author":"MP Stokkel","year":"2010","unstructured":"Stokkel MP, Handkiewicz Junak D, Lassmann M, Dietlein M, Luster M. EANM procedure guidelines for therapy of benign thyroid disease. Eur J Nucl Med Mol Imaging. 2010;37:2218\u201328.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2163_CR18","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1177\/1535370215602784","volume":"241","author":"Y Ding","year":"2016","unstructured":"Ding Y, Xing J, Fang Y, Wang Y, Zhang Y, Long Y. 131I therapy for 345 patients with refractory severe hyperthyroidism: without antithyroid drug pretreatment. Exp Biol Med (Maywood). 2016;241:290\u20135.","journal-title":"Exp Biol Med (Maywood)"},{"key":"2163_CR19","first-page":"1299","volume":"42","author":"\u00dcE VURDEM","year":"2012","unstructured":"VURDEM \u00dcE, Acer N, Ertekin T, Savranlar A, TOPUZ \u00d6, Keceli M. Comparison of three volumetric techniques for estimating thyroid gland volume. Turk J Med Sci. 2012;42:1299\u2013306.","journal-title":"Turk J Med Sci"},{"key":"2163_CR20","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1089\/thy.2007.0399","volume":"18","author":"P Trimboli","year":"2008","unstructured":"Trimboli P, Ruggieri M, Fumarola A, D\u2019Al\u00f2 M, Straniero A, Maiuolo A, et al. A mathematical formula to estimate in vivo thyroid volume from two-dimensional ultrasonography. Thyroid. 2008;18:879\u201382.","journal-title":"Thyroid"},{"key":"2163_CR21","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3803\/EnM.2022.1418","volume":"37","author":"MJ Kim","year":"2022","unstructured":"Kim MJ, Cho SW, Kim YA, Choi HS, Park YJ, Park DJ, et al. Clinical outcomes of repeated radioactive iodine therapy for Graves\u2019 Disease. Endocrinol Metab (Seoul). 2022;37:524\u201332.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"2163_CR22","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/RLU.0000000000000840","volume":"40","author":"MT Sapienza","year":"2015","unstructured":"Sapienza MT, Coura-Filho GB, Willegaignon J, Watanabe T, Duarte PS, Buchpiguel CA. Clinical and dosimetric variables related to outcome after treatment of graves\u2019 disease with 550 and 1110 MBq of 131I: results of a prospective randomized trial. Clin Nucl Med. 2015;40:715\u20139.","journal-title":"Clin Nucl Med"},{"key":"2163_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-82521-5","volume":"14","author":"A Zhao","year":"2024","unstructured":"Zhao A, Zhang J, Xue J, Lu X, Wang Q, Ji T, et al. Predictive factors influencing hypothyroidism following the radioactive iodine treatment of Graves\u2019 disease in different periods. Sci Rep. 2024;14:31148.","journal-title":"Sci Rep"},{"key":"2163_CR24","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1089\/thy.2016.0500","volume":"27","author":"GA Rubio","year":"2017","unstructured":"Rubio GA, Koru-Sengul T, Vaghaiwalla TM, Parikh PP, Farra JC, Lew JI. Postoperative outcomes in graves\u2019 disease patients: results from the nationwide inpatient sample database. Thyroid. 2017;27:825\u201331.","journal-title":"Thyroid"},{"key":"2163_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijsu.2016.01.032","volume":"27","author":"YS Lin","year":"2016","unstructured":"Lin YS, Wu HY, Lee CW, Hsu CC, Chao TC, Yu MC. Surgical management of substernal goitres at a tertiary referral centre: a retrospective cohort study of 2,104 patients. Int J Surg (London England). 2016;27:46\u201352.","journal-title":"Int J Surg (London England)"},{"key":"2163_CR26","doi-asserted-by":"crossref","unstructured":"Chiu SJ, Putri C, Allahabadia A, Balasubramanian SP, Presenting, Salvi SM. Presenting. Reactivation of graves\u2019 ophthalmopathy post-thyroidectomy for graves\u2019 disease. Br J Surg. 2022;109.","DOI":"10.1093\/bjs\/znac056.001"},{"key":"2163_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1757-1626-0002-0000008479","volume":"2","author":"AM Neto","year":"2009","unstructured":"Neto AM, Tambascia MA, Brunetto S, Ramos CD, Zantut-Wittmann DE. Extremely high doses of radioiodine required for treatment of Graves\u2019 hyperthyroidism: a case report. Cases J. 2009;2:8479.","journal-title":"Cases J"},{"key":"2163_CR28","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1089\/thy.2019.0563","volume":"30","author":"E Horvath","year":"2020","unstructured":"Horvath E, Skoknic V, Majlis S, Tala H, Silva C, Castillo E, et al. Radioiodine-induced salivary gland damage detected by ultrasonography in patients treated for papillary thyroid cancer: radioactive iodine activity and risk. Thyroid. 2020;30:1646\u201355.","journal-title":"Thyroid"},{"key":"2163_CR29","doi-asserted-by":"publisher","first-page":"29s","DOI":"10.2967\/jnumed.123.266968","volume":"65","author":"W Yang","year":"2024","unstructured":"Yang W, Kang F, Chen Y, Zhu Z, Wang F, Qin C, et al. Landscape of nuclear medicine in China and its progress on theranostics. J Nucl Med. 2024;65:29s\u201337s.","journal-title":"J Nucl Med"},{"key":"2163_CR30","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/cen.14136","volume":"92","author":"PN Taylor","year":"2020","unstructured":"Taylor PN, Okosieme OE, Chatterjee K, Boelaert K. Joint statement from the Society for Endocrinology and the British Thyroid Association regarding \u201cAssociation of Radioactive Iodine Treatment with cancer mortality in patients with hyperthyroidism.\u201d Clin Endocrinol (Oxf). 2020;92:266\u20137.","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02163-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-026-02163-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02163-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T08:19:31Z","timestamp":1779956371000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-026-02163-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2163"],"URL":"https:\/\/doi.org\/10.1007\/s12149-026-02163-7","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No potential conflicts of interest were disclosed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}